{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:16:40Z","timestamp":1771039000369,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000961","name":"State Health Research Advisory Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000961","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s40265-017-0762-9","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:27:26Z","timestamp":1495499246000},"page":"1199-1210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0841-2216","authenticated-orcid":false,"given":"Erin","family":"Kelty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Hulse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"issue":"4","key":"762_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130100909","volume":"159","author":"S Comer","year":"2002","unstructured":"Comer S, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology. 2002;159(4):351\u201360.","journal-title":"Psychopharmacology"},{"issue":"10","key":"762_CR2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archgenpsychiatry.2009.130","volume":"66","author":"GK Hulse","year":"2009","unstructured":"Hulse GK, Morris N, Arnold-Reed D, Tait RJ. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone. Arch Gen Psychiatry. 2009;66(10):1108\u201315.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"762_CR3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jcem-66-6-1181","volume":"66","author":"SK Teoh","year":"1988","unstructured":"Teoh SK, Mendelson JH, Mello NK, Skupny A. Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle. J Clin Endocrinol Metab. 1988;66(6):1181\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"762_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0091-3057(86)90356-4","volume":"24","author":"JH Mendelson","year":"1986","unstructured":"Mendelson JH, Mello NK, Cristofaro P, Skupny A, Ellingboe J. Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function. Pharmacol Biochem Behav. 1986;24(2):309\u201313.","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"762_CR5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0015-0282(16)57908-4","volume":"64","author":"AD Genazzani","year":"1995","unstructured":"Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Genazzani AR. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea. Fertil Steril. 1995;64(5):951\u20136.","journal-title":"Fertil Steril"},{"issue":"4","key":"762_CR6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0015-0282(16)54956-5","volume":"57","author":"MC Armeanu","year":"1992","unstructured":"Armeanu MC, Berkhout GM, Schoemaker J. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment. Fertil Steril. 1992;57(4):762\u201370.","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"762_CR7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humrep\/8.suppl_2.184","volume":"8","author":"G Leyendecker","year":"1993","unstructured":"Leyendecker G, Waibel-Treber S, Wildt L. Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea. Hum Reprod. 1993;8(Suppl 2):184\u20138.","journal-title":"Hum Reprod"},{"issue":"2","key":"762_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.2012.03811.x","volume":"108","author":"HE Jones","year":"2013","unstructured":"Jones HE, Chisolm MS, Jansson LM, Terplan M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction. 2013;108(2):233\u201347.","journal-title":"Addiction"},{"issue":"5","key":"762_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.0004-8666.2003.00121.x","volume":"43","author":"GK Hulse","year":"2003","unstructured":"Hulse GK, Arnold-Reed DE, O\u2019Neil G, Hansson RC. Naltrexone implant and blood naltrexone levels over pregnancy. Aust N Z J Obstet Gynaecol. 2003;43(5):386\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"762_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.0004-8666.2002.548_14.x","volume":"42","author":"GK Hulse","year":"2002","unstructured":"Hulse GK, O\u2019Neil G. Using naltrexone implants in the management of the pregnant heroin user. Aust N Z J Obstet Gynaecol. 2002;42(5):102\u20136.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"762_CR11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijgo.2003.10.001","volume":"85","author":"GK Hulse","year":"2004","unstructured":"Hulse GK, O\u2019Neil G, Arnold-Reed DA. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user. Int J Gynecol Obstet. 2004;85:170\u20131.","journal-title":"Int J Gynecol Obstet."},{"issue":"2","key":"762_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157015908784533842","volume":"6","author":"WO Farid","year":"2008","unstructured":"Farid WO, Dunlop SA, Tait RJ, Hulse GK. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol. 2008;6(2):125\u201350.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"762_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/14767058.2011.600371","volume":"25","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med. 2012;25(2):109\u201312.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"4497","key":"762_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.7195068","volume":"212","author":"L Lichtblau","year":"1981","unstructured":"Lichtblau L, Sparber SB. Opiate withdrawal in utero increases neonatal morbidity in the rat. Science. 1981;212(4497):943\u20135.","journal-title":"Science"},{"issue":"10","key":"762_CR15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1360-0443.2012.03910.x","volume":"107","author":"E Kelty","year":"2012","unstructured":"Kelty E, Hulse G. Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use. Addiction. 2012;107(10):1817\u201324.","journal-title":"Addiction"},{"issue":"1","key":"762_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/dar.12205","volume":"34","author":"L Degenhardt","year":"2015","unstructured":"Degenhardt L, Larney S, Kimber J, Farrell M, Hall W. Excess mortality among opioid-using patients treated with oral naltrexone in Australia. Drug Alcohol Rev. 2015;34(1):90\u20136.","journal-title":"Drug Alcohol Rev."},{"issue":"1","key":"762_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2007.06.007","volume":"32","author":"HTT Ngo","year":"2008","unstructured":"Ngo HTT, Arnold-Reed DE, Hansson RC, Tait RJ, Hulse GK. Blood naltrexone levels over time following naltrexone implant. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):23\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"762_CR18","volume-title":"Socio-economic indexes for areas: robustness, diversity within larger areas and the new geography standard","author":"P Radisich","year":"2012","unstructured":"Radisich P, Wise P. Socio-economic indexes for areas: robustness, diversity within larger areas and the new geography standard. Canberra: Australian Bureau of Statistics; 2012."},{"issue":"3","key":"762_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1442-2026.2002.00371.x","volume":"14","author":"Australasian College for Emergency Medicine","year":"2002","unstructured":"Australasian College for Emergency Medicine. The Australasian Triage Scale. Emerg Med (Freemantle). 2002;14(3):335\u20136.","journal-title":"Emerg Med (Freemantle)."},{"key":"762_CR20","volume-title":"Maternal deaths in Australia, 2006\u20132010","author":"S Johnson","year":"2014","unstructured":"Johnson S, Bonello MR, Li Z, Hilder L, Sullivan EA. Maternal deaths in Australia, 2006\u20132010. Canberra: Australian Institute of Health and Welfare; 2014."},{"key":"762_CR21","first-page":"1406","volume":"2009","author":"R Varma","year":"2009","unstructured":"Varma R, Gupta J. Tubal ectopic pregnancy. BMJ Clin Evid. 2009;2009:1406.","journal-title":"BMJ Clin Evid."},{"issue":"4","key":"762_CR22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/humupd\/dmp057","volume":"16","author":"JL Shaw","year":"2010","unstructured":"Shaw JL, Dey SK, Critchley HO, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update. 2010;16(4):432\u201344.","journal-title":"Hum Reprod Update."},{"issue":"4","key":"762_CR23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.96.4.1722","volume":"96","author":"AG Faletti","year":"1999","unstructured":"Faletti AG, Mastronardi CA, Lomniczi A, Seilicovich A, Gimeno M, McCann SM, et al. \u03b2-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proc Natl Acad Sci U S A. 1999;96(4):1722\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"762_CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.fertnstert.2009.04.020","volume":"94","author":"M Al-Azemi","year":"2010","unstructured":"Al-Azemi M, Refaat B, Amer S, Ola B, Chapman N, Ledger W. The expression of inducible nitric oxide synthase in the human fallopian tube during the menstrual cycle and in ectopic pregnancy. Fertil Steril. 2010;94(3):833\u201340.","journal-title":"Fertil Steril"},{"issue":"2","key":"762_CR25","first-page":"179","volume":"14","author":"BJ Dattel","year":"1990","unstructured":"Dattel BJ. Substance abuse in pregnancy. Semin Perinatol. 1990;14(2):179\u201387.","journal-title":"Semin Perinatol"},{"issue":"1","key":"762_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1095\/biolreprod.109.082222","volume":"83","author":"A Klukovits","year":"2010","unstructured":"Klukovits A, Tekes K, G\u00fcnd\u00fcz Cinar O, Benyhe S, Borsodi A, De\u00e1k BH, et al. Nociceptin inhibits uterine contractions in term-pregnant rats by signaling through multiple pathways. Biol Reprod. 2010;83(1):36\u201341.","journal-title":"Biol Reprod"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-017-0762-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-017-0762-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-017-0762-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T01:31:17Z","timestamp":1499391077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-017-0762-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1007\/s40265-017-0762-9","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}